Low risk of hepatitis B reactivation in patients with severe COVID‐19 who receive immunosuppressive therapy-Reference-Cited by-同舟云学术

Low risk of hepatitis B reactivation in patients with severe COVID‐19 who receive immunosuppressive therapy

Published:2020-10-12 Issue:1 Volume:28 Page:89-94
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:Journal of Viral Hepatitis

Author:

Rodríguez‐Tajes Sergio¹²^ORCID,Miralpeix Anna¹²,Costa Josep²³,López‐Suñé Ester⁴,Laguno Montserrat⁵,Pocurull Anna¹^ORCID,Lens Sabela¹²^ORCID,Mariño Zoe¹²,Forns Xavier¹²^ORCID

Affiliation:

1. Liver Unit Hospital Clínic IDIBAPSUniversity of Barcelona Barcelona Spain

2. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd) Madrid Spain

3. Microbiology Department Hospital Clínic University of Barcelona Barcelona Spain

4. Pharmacy Service Division of Medicines Hospital Clínic IDIBAPSUniversity of Barcelona Barcelona Spain

5. Infectious Disease Service Hospital Clinic IDIBAPSUniversity of Barcelona Barcelona Spain

Funder

Instituto de Salud Carlos III

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.13410

Reference15 articles.

1. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID‐19 in the New York City area;Richardson S;JAMA,2020

2. Clinical Characteristics of Coronavirus Disease 2019 in China

3. The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease

4. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

5. Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis B reactivation in PsA patients: an SLR and meta-analysis for IL-17, IL-23 and JAK inhibitors;Rheumatology;2024-08-17

2. Hepatitis B Reactivation and Liver Failure Because of COVID-19 Infection;ACG Case Reports Journal;2024-06-27

3. Chronic hepatitis B in rheumatic diseases: issues of screening and reactivation of infection: A review;Terapevticheskii arkhiv;2024-06-03

4. Hepatitis B Virus Reactivation with Immunosuppression: A Hidden Threat?;Journal of Clinical Medicine;2024-01-11

5. The Risk of Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Receiving Tocilizumab: A Systematic Review and Meta-Analysis;Viruses;2024-01-03